Altered gene expression in T-cell receptor signalling in peripheral blood leucocytes in acute coronary syndrome predicts secondary coronary events

• Takashima, Shin-ichiro

• Usui, Soichiro

• Kurokawa, Keisuke

• Kitano, Teppei

• Kato, Takeshi

• Murai, Hisayoshi

• Furusho, Hiroshi

• Oda, Hiroyuki

• Maruyama, Michiro

• Nagata, Yoshiki

• Usuda, Kazuo

• Kubota, Koji

• Takeshita, Yumie

• Sakai, Yoshio

• Honda, Masao

• Kaneko, Shuichi

• Takamura, Masayuki

抄録

Objective: Comprehensive profiling of gene expression in peripheral blood leucocytes (PBLs) in patients with acute coronary syndrome (ACS) as a prognosticator is needed. We explored the specific profile of gene expression in PBLs in ACS for long-term risk stratification. Methods: 30 patients with ACS who underwent primary percutaneous coronary intervention (PCI) and 15 age-matched adults who participated in medical check-ups were enrolled from three centres. Peripheral blood samples were collected to extract RNA for microarray analyses. Results: During the 5-year follow-up, 36% of this cohort developed the expected non-fatal coronary events (NFEs) of target lesion revascularisation (TLR) and PCI for a de novo lesion. Class comparison analysis (p<0.005) demonstrated that 83 genes among 7785 prefiltered genes (41 upregulated vs 42 downregulated genes) were extracted to classify the patients according to the occurrence of NFE. Pathway analysis based on gene ontology revealed that the NFEs were associated with altered gene expression regarding the T-cell receptor signalling pathway in ACS. Univariate t test showed that the expression level of death-associated protein kinase1 (DAPK1), known to regulate inflammation, was the most significantly negatively regulated gene in the event group (0.61-fold, p<0.0005). Kaplan-Meier curve analysis and multivariate analysis adjusted for baseline characteristics or clinical biomarkers demonstrated that lower DAPK1 expression in PBL emerged as an independent risk factor for the NFEs (HR: 8.73; CI 1.05 to 72.8, p=0.045). Conclusions: Altered gene expression in T-cell receptor signalling in PBL in ACS could be a prognosticator for secondary coronary events. © Published by the BMJ Publishing Group Limited.

収録刊行物

• Open Heart

  Open Heart 3 (1), e000400-, 2016-06-01

  BMJ Publishing Group

詳細情報

• CRID: 1050564285907128064
• NII論文ID: 120005830627
• ISSN: 20533624
• Web Site: http://hdl.handle.net/2297/45929
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • CiNii Articles